Seretide withdrawal increases airway inflammation in moderate COPD patients

European Journal of Clinical Pharmacology

Volumn 65, Issue 11, 2009, Pages 1165-1166

  Borrill, Zoe ^a   Roy, Kay ^a   Kolsum, Umme ^a   Southworth, Tom ^a   Vestbo, Jorgen ^b   Singh, Dave ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL;

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LETTER; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AGED; AIRWAY OBSTRUCTION; ALBUTEROL; ANDROSTADIENES; DRUG COMBINATIONS; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 70350232042     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0697-5     Document Type: Letter

References (3)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Available at: http://www.goldcopd.org
2. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J Vestbo TORCH investigators 2007 Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 775 789 10.1056/NEJMoa063070 1:CAS:528:DC%2BD2sXhvFKltL0%3D 17314337 (Pubitemid 46294610)
3. P Calverley R Pauwels J Vestbo P Jones N Pride A Gulsvik J Anderson C Maden 2003 Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial Lancet 361 449 456 10.1016/S0140-6736(03)12459-2 1:CAS:528:DC%2BD3sXhtVahur4%3D 12583942 (Pubitemid 36173708)